For most patients with lumbar disc herniation and sciatica (radiculopathy), guidelines recommend initial conservative care for ~6 weeks: education, activity modification, NSAIDs, and physical therapy. Imaging (MRI) is prioritized for red flags or for symptoms persisting beyond this period. If severe or persistent radicular pain remains, epidural steroid injections (ESIs) may be offered. Microdiscectomy is indicated for progressive neurologic deficit or refractory radicular pain after a conservative trial. PMCACR AC SearchSpine
ESIs: typically provide small, short-term relief (weeks to a few months) and don’t change long-term surgery rates; rare but serious complications are documented. PubMedCenters for Medicare & Medicaid ServicesU.S. Food and Drug Administration
Surgery (microdiscectomy): excellent for fast leg-pain relief in selected patients, but recurrence/re-operation occurs (≈3–24%) and outcomes are worse when surgery is delayed too long. PMC+1
The net: standard care is symptom-first, not disc-repair-first. It often manages pain without restoring disc mechanics.
Classic intradiscal pressure work shows lying ~25 mmHg, standing ~100 mmHg, sitting higher; these are positive pressures. Inversion can lower load but doesn’t produce negative pressure inside the disc—so it can’t create the “vacuum effect” needed to retract herniation material. PubMedFONAR
By contrast, vertebral axial decompression research directly measured negative intradiscal pressure (≈ –100 to –150 mmHg) during treatment—physiology you can’t get from simple traction or inversion. This is the theoretical engine behind true decompression devices like the DRX9000. PubMedmariettachiropractic.com
Beyond pain scores, multiple studies report structural improvements:
Disc height increases alongside pain reduction in prospective imaging cohorts. PMC
Disc volume/herniation size reductions on MRI after NSD in subacute radiculopathy. PMC
Case-series with DRX9000 (2025): after 20 sessions, MRI showed disc height and canal A-P diameter increases with large clinical gains; early but compelling for “buying real estate” around the nerve root/spinal canal. Journal of Contemporary Chiropractic
Ongoing randomized, double-blinded proof-of-concept trial (registered 2025) is collecting biomechanical + MRI endpoints—exactly what payers are asking to see. ClinicalTrials.gov
Bottom line: the direction of high-quality evidence is moving from symptom relief toward objective MRI change with decompression protocols—precisely the kind of evidence that can shift coverage.
Short answer: payers still file Non-Surgical Decompression under “motorized traction/experimental.” Here’s why—and what’s changing.
Medicare (CMS) explicitly lists non-surgical decompression (e.g., VAX-D, DRX9000, others) as non-covered under existing NCD/LCD language. Centers for Medicare & Medicaid Services
Commercial policies (e.g., UnitedHealthcare) label motorized traction unproven/not medically necessary, citing insufficient randomized evidence with durable outcomes; common “S9090” decompression code has no RVU and isn’t payable. UHC Providerchirohealthusa.com
What they want to see: large, well-controlled, assessor-blinded/sham-controlled trials with imaging endpoints and durable follow-up. Historically, decompression studies were small, heterogeneous and protocol-variable—hence the “investigational” tag. That’s exactly why new MRI-based work (above) matters.
Mechanism: Unlike traction, DRX-class decompression uses sensor-driven, logarithmic pull profiles to defeat muscle guarding and maintain sustained negative intradiscal pressure, creating a nutrient-rich environment for disc recovery. (Mechanism established by direct pressure measurement; protocol refinements unique to true decompression systems.) PubMed
Clinical thesis: If you can repeatedly create negative pressure and maintain session-to-session precision, you can:
Retract herniation material and increase disc height (MRI-observable)
Expand canal/foraminal space (“buy real estate” around the nerve root)
Reduce need for escalations (repeat ESIs, surgery) for a sizable subset of patients
Early-to-mid-level evidence already shows disc height/volume gains with meaningful symptom relief; larger trials are underway to satisfy payer thresholds. PMC+1Journal of Contemporary ChiropracticClinicalTrials.gov
Today’s default: rest/meds/PT → maybe injections → maybe surgery. Helpful, but often pain-first and temporary. PMCCenters for Medicare & Medicaid Services
Decompression’s promise: a disc-first approach that doesn’t just mask pain—it changes the physics inside the disc, with growing MRI evidence of more space around the nerve. That’s why clinicians using DRX9000 see patients who avoid or postpone surgery. (Insurers lag because they want bigger, longer, blinded trials; those are in motion.) PMC+1ClinicalTrials.gov
Q: Why isn’t it covered yet?
A: Current CMS and many commercial policies still categorize NSD as investigational—primarily due to historical variability in study quality and protocols. Newer MRI-based and registered randomized trials are closing that gap, but policies update slowly. Centers for Medicare & Medicaid ServicesUHC Provider
Q: Is decompression the same as traction or inversion?
A: No. Traction/inversion reduce load but don’t create negative intradiscal pressure. DRX-class decompression does, which appears necessary for herniation retraction and rehydration. PubMed+1
Q: Where does surgery fit now?
A: Surgery remains the gold standard for progressive deficits or refractory, disabling leg pain—especially early for best outcomes—but it carries recurrence/re-op risk. A robust decompression program gives many patients a non-operative, disc-repair-first path. PMC+1
_________________________________________________________________________________________________
Not every “decompression” table is the same. If you’ve tried therapy or injections and still feel the pinch, ask about DRX9000 true spinal decompression—engineered to create negative disc pressure and documented MRI changes. Book a no-pressure consult to see if you’re a candidate.
___________________________________________________________________________________________________________
This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before beginning any new therapy, supplement, or exercise program. Results may vary, and no guarantees of specific outcomes are made.
Dr. David Kaff, DC is the founder of Frisco Spinal Rehab, serving the Frisco and North Texas community for over 25 years. His clinic specializes in advanced DRX9000 True Spinal Decompression, integrative chiropractic care, massage therapy, and supportive modalities to help patients recover from disc injuries, sciatica, and chronic back pain.
Find out more – https://drx.friscorehab.com/landing-page